Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q3

Stryker, Johnson & Johnson and Zimmer Biomet posted their third quarter financial results, along with data on how their orthopedic segments performed.

Advertisement

Here is how their third-quarter finances compare:

 

Stryker 

Total sales: $4.5 billion (+7.7 percent) 

Orthopedics and spine: $1.9 billion (+4.4 percent) 

Hips: $347 million (+5.6 percent)

Knees: $481 million (+9.6 percent)

Johnson & Johnson

Total sales: $23.8 billion (+1.9 percent)

Spine, sports and other: $708 million (+0.3 percent) 

Orthopedic: $2.0 billion (+0.1 percent) 

Hips: $352 million (-0.9 percent)

Knees: $317 million (+0.4 percent)

Zimmer Biomet

Total sales: $1.7 billion (-0.9 percent)

Hips: $468 million (+3.1 percent) 

Knees: $657 million (+1.4 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $409.4 million (-6.4 percent)

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.